CAMBENDAZOLE
UNII 079X63S3DU

Substance Identification & Data

This profile provides standardized clinical and technical data for Cambendazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 079X63S3DU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 26097-80-3 and the RxNorm Concept ID (RxCUI) 1951. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

079X63S3DU

CAS Registry Number

26097-80-3

RxNorm Concept ID

1951

Detailed Substance Profile

Preferred Name

CAMBENDAZOLE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C14H14N4O2S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QZWHWHNCPFEXLL-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C75212

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

33309

Unique identification number in the NCBI database of chemical substances.

INN ID

2931

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(nc2ccc(NC(=O)OC(C)C)cc2[nH]1)-c3ncsc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cambendazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.